{"id":4195,"date":"2024-10-28T18:03:41","date_gmt":"2024-10-28T18:03:41","guid":{"rendered":"https:\/\/investingsstrategist.com\/index.php\/2024\/10\/28\/top-stock-gainers-and-losers-ibrx-26-37-cpri-48-89\/"},"modified":"2024-10-28T18:03:41","modified_gmt":"2024-10-28T18:03:41","slug":"top-stock-gainers-and-losers-ibrx-26-37-cpri-48-89","status":"publish","type":"post","link":"https:\/\/investingsstrategist.com\/index.php\/2024\/10\/28\/top-stock-gainers-and-losers-ibrx-26-37-cpri-48-89\/","title":{"rendered":"Top Stock Gainers And Losers: IBRX +26.37%, CPRI -48.89%"},"content":{"rendered":"
\n

Top Gainers<\/h2>\n

Symbol
\nCompany Name
\nPrice
\nChange
\nChange %<\/p>\n

IBRX
\nImmunityBio, Inc.\u00a0
\n5.32
\n+1.11
\n+26.37%<\/p>\n

Zk
\nZEEKR Intelligent Technology Holding Limited
\n28.85
\n+5.74
\n+24.84%<\/p>\n

NWL
\nNewell Brands Inc.
\n8.73
\n+1.55
\n+21.59%<\/p>\n

TPR
\nTapestry, Inc.\u00a0
\n50.49
\n+6.02
\n+13.54%<\/p>\n

DJT
\nTrump Media & Technology Group Corp.
\n38.95
\n+4
\n+11.44%<\/p>\n

Top Losers<\/h2>\n

Symbol
\nCompany Name
\nPrice
\nChange
\nChange %<\/p>\n

CPRI
\nCapri Holdings Limited\u00a0
\n21.26
\n-20.34
\n-48.89%<\/p>\n

JOBY
\nJoby Aviation, Inc.\u00a0
\n5.16
\n-0.88
\n-14.57%<\/p>\n

TBBK
\nThe Bancorp, Inc.\u00a0
\n47.01
\n-7.95
\n-14.47%<\/p>\n

MHK
\nMohawk Industries, Inc.\u00a0
\n130.88
\n-20.99
\n-13.82<\/p>\n

CRI
\nCarter\u2019s Inc.
\n56.95
\n-8.74
\n-13.30%<\/p>\n

\u00a0<\/p>\n

After a sideways opening market tried holding on to higher levels, but as of the last few trading sessions, selling continued in the market after an hour or two.\u00a0\u00a0<\/span><\/p>\n

NYSE Composite:<\/strong> -104.4 (-0.53%)<\/span>
\nDow Jones:<\/strong> -259.96 (-0.61%)<\/span>
\nS&P 500:<\/strong> -1.76 (+0.03%)<\/span><\/p>\n

#1 Gainer: IBRX Stock<\/span><\/h2>\n

ImmunityBio Inc. (NASDAQ: IBRX<\/a>) stock <\/span>turned out to be the top gainer after delivering nearly +77% returns in a single day and, by the end of the day, closing at +26.37%.\u00a0<\/span><\/p>\n

ImmunityBio Inc. rallied for two consecutive days as the company<\/a> announced the initiation of doses in phase 1 for CD19 t-haNK cell therapy. The trial has been named QUILT 106. This testing will be done on 100 patients looking for a cure in natural killer cell-based cellular therapy like non-Hodgkin lymphoma, a cancer of the lymphatic system. This trial is being conducted in Johannesburg, Pretoria and Bloemfontein.\u00a0<\/span><\/p>\n

The investors are keeping high hopes with the upcoming results of the trial, as this can be a game changer for both company and market movers<\/a>.\u00a0<\/span><\/p>\n

IBRX Stock 15-Minute Chart<\/em><\/p>\n

The stock broke all the above resistance after delivering staggering returns of +26.37 in a single day. Making an entry due to FOMO can result in risking huge amounts of money. Looking into the technicals on the 1-day time frame. We can clearly see the stock was selling for a long time.<\/p>\n

Before giving a breakout, the price was in the channel, as marked in the image. Buyers were taking a position in the sock<\/a>. Looking at the current situation, the market made an inverted pin bar like a candle which indicates heavy selling from higher levels.\u00a0<\/span><\/p>\n

You can enter if the price retests the $3.95 level. Place your stop loss at $2.90 and set targets at $6.77 and $7.63.<\/p>\n

#1 Loser: CPRI Stock<\/strong><\/h2>\n

Capri Holdings Limited (NASDAQ: CPRI) stock faced a -48.89% decline in just one single day, wiping out $2.2 billion from the market cap.\u00a0<\/span><\/p>\n

The stock tumbled after a judge blocked the $8.5 billion tapestry deal, making it difficult for the company<\/a> to sustain in luxury brand competition. This deal was proposed last year to compete with European giants by bringing major brands under one roof.\u00a0<\/span><\/p>\n

Due to inflation and current market conditions, luxury brands face challenges due to customers focusing on essential buying. This makes it hard for the company to sustain itself.\u00a0<\/span><\/p>\n

Capri could plan to seek another suitor, said Dana Telsey of Telsey Advisory Group, but with the delay in the deal and weak results, investors are looking for their trust in the stock.\u00a0<\/span><\/p>\n<\/p>\n

CPRI\/USD 15-Minute Chart<\/em><\/p>\n

After facing a huge selling of -48.89%, the market is in a selling trend on a weekly time frame. RSI<\/a> is near 30 levels, indicating selling pressure is still ongoing.\u00a0<\/span><\/p>\n

The selling position could trigger if the price breaks the previous day\u2019s low ($20.99) with a target of $8.38 and a stop-loss of $31.69.\u00a0<\/span><\/p>\n

The post Top Stock Gainers And Losers: IBRX +26.37%, CPRI -48.89%<\/a> appeared first on FinanceBrokerage<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Top Gainers Symbol Company Name Price Change Change % IBRX ImmunityBio, Inc.\u00a0 5.32 +1.11 +26.37% Zk ZEEKR Intelligent Technology Holding Limited 28.85 +5.74 +24.84% NWL Newell Brands Inc. 8.73 +1.55 +21.59% TPR Tapestry, Inc.\u00a0 50.49 +6.02 +13.54% DJT Trump Media & Technology Group Corp. 38.95 +4 +11.44% Top Losers Symbol Company Name Price Change Change […]<\/p>\n","protected":false},"author":0,"featured_media":4196,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-4195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economy"],"_links":{"self":[{"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/posts\/4195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/comments?post=4195"}],"version-history":[{"count":0,"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/posts\/4195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/media\/4196"}],"wp:attachment":[{"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/media?parent=4195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/categories?post=4195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/investingsstrategist.com\/index.php\/wp-json\/wp\/v2\/tags?post=4195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}